A Comparison Study for Chances of Reduction in Cardiovascular Risk by Draksharishta in Induced Diabetic Condition by Subhajit Ghosh in DDIPIJ in Lupine Publishers
In this study was to evaluate the effect of Draksharishta-T and
Draksharishta -M prepared by traditional and modern methods
respectively and Dabur Draksharishta and comparison between them on
fasting blood glucose and serum lipid profile in alloxan
induced diabetic rats. Oral administration of Draksharishta-T,
Draksharishta-M and Dabur Draksharishta (2ml/kg p.o.) for 21 days
caused a significant decrease in fasting blood glucose (FBG) and showed
significant rise in blood glutathione level (GSH) in diabetic
rats. Glibenclamide was used as a standard anti diabetic drug (10 mg/kg,
p.o). These preparations also caused significant reduction
in serum cholesterol, LDL and triglycerides and showed significant rise
in serum HDL level in diabetic albino rats. Thus all these
preparations were able to maintain the tested parameters near to the
normal level significantly.
For more Lupine Publishers Open Access Journals Please visit our website: http://www.lupinepublishers.com/
For more Healthcare Open Access Journal articles Please Click Here: http://www.lupinepublishers.com/drug-designing-journal/
No comments:
Post a Comment